Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess

Diabetes Metab. 2016 Jun;42(3):196-9. doi: 10.1016/j.diabet.2015.10.004. Epub 2015 Nov 3.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Cyproterone Acetate / therapeutic use*
  • Drug Combinations
  • Ethinyl Estradiol / therapeutic use*
  • Female
  • Fibroblast Growth Factors / blood*
  • Flutamide / administration & dosage*
  • Hirsutism / blood
  • Hirsutism / drug therapy
  • Hirsutism / etiology
  • Humans
  • Hyperandrogenism / blood
  • Hyperandrogenism / complications
  • Hyperandrogenism / drug therapy*
  • Hyperinsulinism / blood
  • Hyperinsulinism / complications
  • Hyperinsulinism / drug therapy
  • Longitudinal Studies
  • Metformin / administration & dosage*
  • Pioglitazone
  • Thiazolidinediones / administration & dosage*

Substances

  • Drug Combinations
  • Thiazolidinediones
  • fibroblast growth factor 21
  • Ethinyl Estradiol
  • Cyproterone Acetate
  • Cyproterone acetate, ethinyl estradiol drug combination
  • Fibroblast Growth Factors
  • Flutamide
  • Metformin
  • Pioglitazone